𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multidrug resistance in cancer cells, molecular, biochemical, physiological and biological aspects


Book ID
108422142
Publisher
Elsevier Science
Year
1997
Tongue
French
Weight
135 KB
Volume
32
Category
Article
ISSN
0223-5234

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gene amplification in multidrug-resistan
✍ Andrey Gudkov; Boris Kopnin πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 659 KB

## Multidrug resistance (MDR) is developed in a population of somatic mammalian cells in vivo or in vitro when they are selected for resistance to each of a large group of drugs (colchicine, adriamycin, actinomycin D , etc.). It isproduced by the amplification of some unknown gene@) whose praduct(s)

Elevation of glucosylceramide in multidr
✍ Hamid Morjani; NassΓ©ra Aouali; Rajae Belhoussine; Robert Jan Veldman; Thierry Le πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 261 KB

Multidrug-resistant (MDR) cancer cells have been shown to have an accumulation of glucosylceramide (GlcCer). In this study, we aim at localizing, at subcellular level, where these lipids accumulate. Neutral lipids and phospholipid containing organelles have been identified using confocal fluorescenc

Changes in phospholipase D isoform activ
✍ Giusy Fiucci; Malgorzata Czarny; Yaakov Lavie; Di Zhao; Brygida Berse; J. Krzysz πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 171 KB

Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy and is often associated with elevated expression of drug transporters such as P-glycoprotein (P-gp) in the cancer cells. MDR is, however, accompanied by additional biochemical changes including modifications of membrane co